# Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients

> **NCT03758014** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd** · enrollment: 200 (estimated)

## Conditions studied

- GBM

## Interventions

- **DRUG:** Chlorogenic acid for Injection
- **DRUG:** Lomustine

## Key facts

- **NCT ID:** NCT03758014
- **Lead sponsor:** Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-27
- **Primary completion:** 2020-10-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03758014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03758014, "Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03758014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*